Khai Loon Kua serves as Executive at Cyclacel Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Khai Loon Kua has executed 8 insider transactions totaling $1.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 5, 2025 involved transacting 467,535 shares valued at $0.
Khai Loon Kua currently holds 467,535 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Khai Loon Kua has been a net seller of CYCC stock. They have purchased $0 and sold $1.3M worth of shares.
Khai Loon Kua's most recent insider trade was on Nov 5, 2025, when they sold 467,535 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.80 |
| Discretionary |
| Oct 16, 2025 | BGMS | $372.2K | Sale | 88,204 | $4.22 | Discretionary |
| Oct 15, 2025 | BGMS | $42.3K | Sale | 7,479 | $5.66 | Discretionary |
| Sep 16, 2025 | BGMS | $128.3K | Sale | 25,000 | $5.13 | Discretionary |
| Sep 12, 2025 | BGMS | $138.4K | Sale | 22,251 | $6.22 | Discretionary |
| Sep 5, 2025 | CYCC | $133.6K | Sale | 19,054 | $7.01 | Discretionary |
| Sep 4, 2025 | CYCC | $0 | Other | 186,465 | $N/A | Discretionary |